Loading clinical trials...
Loading clinical trials...
Allogeneic Peripheral Blood Stem Cell Transplantation for Patients With Acute Myelogenous Leukemia and Acute Lymphoblastic Leukemia in First or Second Remission or Chronic Myelogenous Leukemia in First and Second Chronic Phase or Accelerated Phase
Conditions
Interventions
Allogeneic hematopoietic cell transplantation
Locations
1
United States
Stanford University School of Medicine
Stanford, California, United States
Start Date
May 1, 2002
Primary Completion Date
April 1, 2009
Completion Date
April 1, 2009
Last Updated
June 16, 2016
NCT06735690
NCT00131014
NCT05564390
NCT03050268
NCT06074666
NCT07320235
Lead Sponsor
Stanford University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions